Erste Asset Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70.1K | Hold |
28,400
| – | – | ﹤0.01% | 842 |
|
|
2025
Q1 | $67K | Hold |
28,400
| – | – | ﹤0.01% | 504 |
|
|
2024
Q4 | $156K | Hold |
28,400
| – | – | ﹤0.01% | 494 |
|
|
2024
Q3 | $239K | Hold |
28,400
| – | – | ﹤0.01% | 474 |
|
|
2024
Q2 | $201K | Hold |
28,400
| – | – | ﹤0.01% | 478 |
|
|
2024
Q1 | $244K | Hold |
28,400
| – | – | ﹤0.01% | 471 |
|
|
2023
Q4 | $191K | Hold |
28,400
| – | – | ﹤0.01% | 482 |
|
|
2023
Q3 | $273K | Hold |
28,400
| – | – | ﹤0.01% | 460 |
|
|
2023
Q2 | $355K | Hold |
28,400
| – | – | 0.01% | 449 |
|
|
2023
Q1 | $383K | Hold |
28,400
| – | – | 0.01% | 448 |
|
|
2022
Q4 | $400K | Hold |
28,400
| – | – | 0.01% | 443 |
|
|
2022
Q3 | $722K | Hold |
28,400
| – | – | 0.02% | 383 |
|
|
2022
Q2 | $790K | Hold |
28,400
| – | – | 0.02% | 382 |
|
|
2022
Q1 | $1.01M | Buy |
+28,400
| New | +$1.01M | 0.02% | 352 |
|